|Articles|November 1, 2003

Single-dose Equivalency Seen

New York - California researchers have challenged the widespread belief among dermatologists that a "triple-dose" methotrexate regimen - in which three small doses of the potent drug are administered in 12-hour intervals -causes less liver toxicity than one large dose given once weekly.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME